Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women

GWAS have identified variation in the FGFR2 locus as risk factors for breast cancer. Validation studies, however, have shown inconsistent results by ethnics and pathological characteristics. To further explore this inconsistency and investigate the associations of FGFR2 variants with breast cancer according to intrinsic subtype (Luminal-A, Luminal-B, ER−&PR−&HER2+, and triple negative) among Southern Han Chinese women, we genotyped rs1078806, rs1219648, rs2420946, rs2981579, and rs2981582 polymorphisms in 609 patients and 882 controls. Significant associations with breast cancer risk were observed for rs2420946, rs2981579, and rs2981582 with OR (95% CI) per risk allele of 1.19 (1.03–1.39), 1.24 (1.07–1.43), and 1.17 (1.01–1.36), respectively. In subtype specific analysis, above three SNPs were significantly associated with increased Luminal-A risk in a dose-dependent manner (P trend < 0.01); however, only rs2981579 was associated with Luminal-B, and none were linked to ER−&PR− subtypes (ER−&PR−&HER2+ and triple negative). Haplotype analyses also identified common haplotypes significantly associated with luminal-like subtypes (Luminal-A and Luminal-B), but not with ER−&PR− subtypes. Our results suggest that associations of FGFR2 SNPs with breast cancer were heterogeneous according to intrinsic subtype. Future studies stratifying patients by their intrinsic subtypes will provide new insights into the complex genetic mechanisms underlying breast cancer.

[1]  J. Long,et al.  Evaluation of Breast Cancer Susceptibility Loci in Chinese Women , 2010, Cancer Epidemiology, Biomarkers and Prevention.

[2]  J. Wang,et al.  Association of MHC class-III gene polymorphisms with ER-positive breast cancer in Chinese Han population. , 2012, Genetics and molecular research : GMR.

[3]  Lotfi Chouchane,et al.  Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians , 2012, Breast Cancer Research and Treatment.

[4]  Xuexi Yang,et al.  Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[5]  Graham A Colditz,et al.  Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.

[6]  Patrick Neven,et al.  Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. , 2011, Human molecular genetics.

[7]  S. Chanock,et al.  Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status , 2008, Clinical Cancer Research.

[8]  Wei Lu,et al.  Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. , 2010, Journal of the National Cancer Institute.

[9]  S. Husain,et al.  A Study on Genetic Variants of Fibroblast Growth Factor Receptor 2 (FGFR2) and the Risk of Breast Cancer from North India , 2014, PloS one.

[10]  A. Børresen-Dale,et al.  Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes , 2007, Breast Cancer Research.

[11]  W. Willett,et al.  A Genome-Wide “Pleiotropy Scan” Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer , 2014, PloS one.

[12]  Joan Valls,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[13]  Guangyu Yao,et al.  Risk-Association of CYP11A1 Polymorphisms and Breast Cancer Among Han Chinese Women in Southern China , 2012, International journal of molecular sciences.

[14]  Giske Ursin,et al.  FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. , 2009, Human molecular genetics.

[15]  I. Casas,et al.  Age at first full-term pregnancy, lactation and parity and risk of breast cancer: A case-control study in Spain , 1996, European Journal of Epidemiology.

[16]  H. Kuerer,et al.  Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy , 2012, Breast Cancer Research.

[17]  M. Pike,et al.  Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies , 2006, Breast Cancer Research.

[18]  Patrick Neven,et al.  Genome-wide association studies identify four ER negative–specific breast cancer risk loci , 2013, Nature Genetics.

[19]  B. Ponder,et al.  Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer , 2008, PLoS biology.

[20]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[21]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[22]  P. Gregersen,et al.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33 , 2008, Proceedings of the National Academy of Sciences.

[23]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Wonshik Han,et al.  Common Genetic Variants Associated with Breast Cancer in Korean Women and Differential Susceptibility According to Intrinsic Subtype , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[25]  Stephen B. Gruber,et al.  FGFR2 Is a Breast Cancer Susceptibility Gene in Jewish and Arab Israeli Populations , 2008, Cancer Epidemiology Biomarkers & Prevention.

[26]  Hongbing Shen,et al.  Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. , 2008, Carcinogenesis.

[27]  Lodewyk F. A. Wessels,et al.  Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response , 2009, Breast Cancer Research and Treatment.

[28]  C. Rotimi,et al.  Genetic Susceptibility Loci for Subtypes of Breast Cancer in an African American Population , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[29]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[30]  J. Haines,et al.  Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.

[31]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[32]  R. Coombes,et al.  Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. , 1992, British Journal of Cancer.

[33]  P. Robson,et al.  Identification of a Breast Cancer Susceptibility Locus at 4q31.22 Using a Genome-Wide Association Study Paradigm , 2013, PloS one.

[34]  He-guang Huang,et al.  Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women. , 2012, The Tohoku journal of experimental medicine.

[35]  J. Wesche,et al.  Fibroblast growth factors and their receptors in cancer. , 2011, The Biochemical journal.

[36]  Fan Chen,et al.  Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality , 2012, Immunogenetics.

[37]  Peter Kraft,et al.  Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics , 2008, PLoS genetics.

[38]  L. Bernstein,et al.  Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast Cancer , 2009, Cancer Epidemiology Biomarkers & Prevention.

[39]  W. Han,et al.  Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis , 2011, Breast Cancer Research.

[40]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[41]  P. Ang,et al.  Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population , 2012, Breast Cancer Research and Treatment.